and IGHV have the strongest impact on a patient’s final result, and it can be therefore not shocking that simplified versions on the CLL-IPI incorporating only these two markers are already proposed. 101 A recent study has determined that a rating based on the presence of unmutated IGHV, complete lymphocyte count >fifteen x109/L, and palpable lym